Elmiron Vision Loss Lawsuit
Elmiron is a bladder pain medication that has been linked to serious vision problems, including maculopathy, vision loss, retina damage, macular degeneration, and other diseases of the eye.
If you or a loved one has been diagnosed with vision problems after taking Elmiron, contact one of our Minnesota Defective Drug Lawyers today. Our team has over 30 years of complex litigation experience and will deliver the Gold standard advocacy you deserve.Call 800-903-1643 >
Case Quick Facts
The common bladder medication, Elmiron, has been linked to the vision-threatening eye condition, maculopathy.
Elmiron vision loss lawsuits claim that the drug causes a unique eye disorder known as maculopathy and other conditions affecting the retina which may lead to blindness. The lawsuits also accuse Janssen Pharmaceutical of failing to properly warn the public about the risk of vision problems associated with the use of Elmiron.
Elmiron (pentosane polysufate sodium) has been on the market since 1996 and is manufactured by Janssen Pharmaceuticals. It is used to treat the bladder condition, interstitial cystitis.
Researchers have concluded that long-term use of the bladder medication Elmiron (pentosane polysufate sodium) may result in damage to the retina known as maculopathy. This is a unique type of maculopathy which has only been found in people taking Elmiron. This condition is distinguishable from age-based degeneration in that it causes a unique pigmentary maculopathy during exposure to Elmiron.
Maculopathy is a progressive disease that can lead to vision loss—usually in both eyes. The disease impacts the part of the eye in the back of the retina that is known as the macula which controls a person’s ability to read, see fine details in objects, recognize faces and colors, and focus central vision.
- Difficulty reading
- Difficulty adapting to dim lighting
- Areas of vision loss in field of vision
- Problems seeing objects that are close by
- Vision dimming
Elmiron was first released for sale in 1996 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Elmiron was marketed by Janssen Pharmaceuticals as a safe and effective treatment for interstitial cystitis and osteoarthiritis. However, Elmiron’s current prescribing information provided by the manufacturer lists the drug’s side effects and warnings but does not include any information about the risk of maculopathy.
Researchers estimate that more than one million people in the United States – the majority of sufferers are women – have the condition of interstitial cystitis. Elmiron has been prescribed to hundreds of thousands of people.
GoldenbergLaw is currently investigating cases where an individual has taken Elmiron and suffered vision problems, including maculopathy, vision loss, retina damage, and other eye diseases. We have been litigating complex cases for over thirty years and will fight to bring you the justice and gold standard of advocacy that you deserve.
Contact us today for a free Elmiron vision loss lawsuit consultation.Do I Qualify?
Elmiron Lawsuit FAQs
If you have taken Elmiron and been diagnosed with vision problems, including maculopathy, macular degeneration, blindness, retaina damage, or other diseases of the eye, you may have a case against the manufacturers. Contact the Elmiron Vision Loss Lawsuit Attorneys at GoldenbergLaw today for a free case evaluation.
Multiple studies have found a significant link between long-term use of Elmiron and maculopathy. Many patients who participated in these studies had been taking Elmiron over a long duration developed maculopathy and other vision problems. Often these vision problems have been misdiagnosed as retinal dystrophy and other disorders of the eye.
Yes. Many users of Elmiron have begun to file lawsuits claiming the medication has caused them to developed vision problems such as maculopathy. If you or a loved one has taken Elmiron and developed vision problems, contact our Minnesota Defective Drug Lawyers for a free Elmiron Vision Loss Lawsuit consultation today.
If you are taking Elmiron and have experienced vision problems, contact your doctor or medical provider to discuss treatment options.
If you have been diagnosed with vision problems after taking Elmiron, you may be entitled to compensation for your injuries. Contact GoldenbergLaw for a free consultation and to learn more about a potential Elmiron vision loss lawsuit.
If you or a loved one developed vision problems after taking Elmiron, contact GoldenbergLaw today for a complementary consultation. We have extensive experience in litigating defective drug cases and believe strongly in promoting safety through accountability.Contact Us Call 800-903-1643
Why Choose GoldenbergLaw?
With over 30 years of experience holding negligent drug manufacturers accountable, our Elmiron Vision Loss Lawsuit litigation team is ready to help you obtain justice. Let us deliver the Gold standard advocacy you deserve.
Thousands of Successful Settlements
Comprehensive Knowledge of Complex Issues
Focused on Client-Centered Solutions
Meet Your Elmiron Team
Have a potential client we could help?
Call us. You’ll sleep better.